STEPHANIE FEELY: Open Payments
NPI 1376901249 · MAYBROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 33 payments from 9 companies in 2025. Trend: 2023 $1,893 · 2024 $1,940 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $188 |
| PFIZER INC. | 5 | $105 |
| Novo Nordisk Inc | 5 | $98 |
| Lilly USA, LLC | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $17 |
Products named: JARDIANCE, XIFAXAN, BREZTRI, AIRSUPRA, Rybelsus, FARXIGA, PREVNAR 20, REXULTI.
Industry payments across NY — which companies pay providers there.
